HSD17B13 and metabolic dysfunction-associated steatotic liver disease: In this work, we showed that HSD17B13 expression was up-regulated in the livers of patients with NAFLD and increased in the livers of multiple murine NAFLD models and hepatocytes treated with etiological agents.